Cargando…

Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency

BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other enviro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Annyce S, Stoller, James K, Vedal, Sverre, Ruttenber, A James, Strand, Matt, Sandhaus, Robert A, Newman, Lee S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707814/
https://www.ncbi.nlm.nih.gov/pubmed/18044105
_version_ 1782169188239933440
author Mayer, Annyce S
Stoller, James K
Vedal, Sverre
Ruttenber, A James
Strand, Matt
Sandhaus, Robert A
Newman, Lee S
author_facet Mayer, Annyce S
Stoller, James K
Vedal, Sverre
Ruttenber, A James
Strand, Matt
Sandhaus, Robert A
Newman, Lee S
author_sort Mayer, Annyce S
collection PubMed
description BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other environmental exposures. METHODS: Environmental exposures were assessed in 313 PI*Z adults through retrospective self-administered questionnaire. Age of onset of symptoms with and without these exposures were analyzed through survival analysis. RESULTS: Personal smoking was the most important risk factor, associated with earlier onset of cough and wheeze, and showed a dose-dependent relationship with the onset of dyspnea. Childhood environmental tobacco smoke (ETS) exposure was independently associated with younger age of onset of cough. Earlier onset of wheeze was also associated with childhood respiratory infections and family history of emphysema. The report of childhood respiratory infections was associated with childhood ETS exposure, but no statistically significant interactions were noted. CONCLUSIONS: We conclude that both personal and secondhand exposure to tobacco smoke in childhood are likely to accelerate the onset of symptoms in AAT deficient patients. Respiratory infections in childhood may also contribute to this risk.
format Text
id pubmed-2707814
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27078142009-07-27 Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency Mayer, Annyce S Stoller, James K Vedal, Sverre Ruttenber, A James Strand, Matt Sandhaus, Robert A Newman, Lee S Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other environmental exposures. METHODS: Environmental exposures were assessed in 313 PI*Z adults through retrospective self-administered questionnaire. Age of onset of symptoms with and without these exposures were analyzed through survival analysis. RESULTS: Personal smoking was the most important risk factor, associated with earlier onset of cough and wheeze, and showed a dose-dependent relationship with the onset of dyspnea. Childhood environmental tobacco smoke (ETS) exposure was independently associated with younger age of onset of cough. Earlier onset of wheeze was also associated with childhood respiratory infections and family history of emphysema. The report of childhood respiratory infections was associated with childhood ETS exposure, but no statistically significant interactions were noted. CONCLUSIONS: We conclude that both personal and secondhand exposure to tobacco smoke in childhood are likely to accelerate the onset of symptoms in AAT deficient patients. Respiratory infections in childhood may also contribute to this risk. Dove Medical Press 2006-12 2006-12 /pmc/articles/PMC2707814/ /pubmed/18044105 Text en © 2006 Dove Medical Press Limited. All rights reserved
spellingShingle Original Research
Mayer, Annyce S
Stoller, James K
Vedal, Sverre
Ruttenber, A James
Strand, Matt
Sandhaus, Robert A
Newman, Lee S
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title_full Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title_fullStr Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title_full_unstemmed Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title_short Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
title_sort risk factors for symptom onset in pi*z alpha-1 antitrypsin deficiency
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707814/
https://www.ncbi.nlm.nih.gov/pubmed/18044105
work_keys_str_mv AT mayerannyces riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT stollerjamesk riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT vedalsverre riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT ruttenberajames riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT strandmatt riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT sandhausroberta riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency
AT newmanlees riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency